O-2372 Explained

O-2372 is an analgesic cannabinoid derivative created by Organix Inc. for use in scientific research. It has high affinity for both CB1 and CB2 receptors, with Ki values of 1.3 nM at CB1 and 0.57 nM at CB2, but is only moderately soluble in water compared to other related compounds such as O-2694, which it is a metabolite of.[1]

See also

Notes and References

  1. Martin BR, Wiley JL, Beletskaya I, Sim-Selley LJ, Smith FL, Dewey WL, Cottney J, Adams J, Baker J, Hill D, Saha B, Zerkowski J, Mahadevan A, Razdan RK . Pharmacological characterization of novel water-soluble cannabinoids . The Journal of Pharmacology and Experimental Therapeutics . 318 . 3 . 1230–9 . September 2006 . 16757541 . 10.1124/jpet.106.104109 . 14864925 .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "O-2372".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.